ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ARWR fundamentals
Arrowhead Pharmaceuticals (ARWR) released its earnings on Nov 25, 2025: revenue was 256.47M (YoY 0.00%), beat estimates; EPS was -0.11 (YoY +91.91%), beat estimates.
Revenue / YoY
256.47M
0.00%
EPS / YoY
-0.11
+91.91%
Report date
Nov 25, 2025
ARWR Earnings Call Summary for Q4,2025
- FDA Breakthrough: First siRNA therapy approved for FCS, addressing 6,500 high-risk patients with $60k/year pricing.
- Pipeline Expansion: 20+ clinical candidates, including Phase III zodasiran (HoFH) and novel dual-target ARO-DIMER-PA.
- Strategic Wins: $400M from Novartis/Sarepta, extending cash runway to 2028.
- CNS Innovation: ARO-MAPT achieves 75% tau knockdown in monkeys, targeting Alzheimer's with CNS delivery.
EPS
Revenue
Revenue & Expenses
ARWR has released its 2025 Q4 earnings report, with revenue of 256.47M, reflecting a YoY change of NaN%, and net profit of 16.12M, showing a YoY change of 109.30%. The Sankey diagram below clearly presents ARWR's revenue sources and cost distribution.
Key Indicators
Arrowhead Pharmaceuticals (ARWR) key financial stats and ratios, covering profitability, financial health, and leverage.
Arrowhead Pharmaceuticals (ARWR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Arrowhead Pharmaceuticals (ARWR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Arrowhead Pharmaceuticals (ARWR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Arrowhead Pharmaceuticals (ARWR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Arrowhead Pharmaceuticals (ARWR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Arrowhead Pharmaceuticals's management provide for the next earnings period?What is Arrowhead Pharmaceuticals's gross profit margin?What were the key takeaways from Arrowhead Pharmaceuticals's earnings call?What is the revenue and EPS growth rate for Arrowhead Pharmaceuticals year over year?What is the market's earnings forecast for Arrowhead Pharmaceuticals next quarter?What does Arrowhead Pharmaceuticals do and what are its main business segments?What is Arrowhead Pharmaceuticals's latest dividend and current dividend yield?Did Arrowhead Pharmaceuticals beat or miss consensus estimates last quarter?
